Literature DB >> 30529196

Arrhythmogenic β-adrenergic signaling in cardiac hypertrophy: The role of small-conductance calcium-activated potassium channels via activation of CaMKII.

Rui Kamada1, Hisashi Yokoshiki2, Hirofumi Mitsuyama1, Masaya Watanabe1, Kazuya Mizukami3, Taro Tenma1, Masayuki Takahashi1, Shingo Takada1, Toshihisa Anzai1.   

Abstract

Sustained ventricular arrhythmias (SVAs) lead to sudden cardiac death, for which β- adrenoreceptor blockers are effective. We hypothesized that electrophysiological changes and arrhythmias by β- adrenoreceptor stimulation are crucially related to activation of small-conductance calcium-activated potassium (SK) channels via the increase in Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity. We used normotensive Wistar-Kyoto (WKY) rats and spontaneous hypertensive rats (SHRs). The latter served as a model of left ventricular hypertrophy. We performed dual optical mapping of action potentials and Ca2+ transients, and the effects of isoproterenol and apamin, an SK channel blocker, were evaluated in the Langendorff-perfused hearts. Action potential duration was abbreviated by isoproterenol (100 nM) in both WKY rats and SHRs. In contrast, the CaMKII activity was increased by isoproterenol only in SHRs. In the presence of isoproterenol, apamin prolonged the action potential duration only in SHRs (n = 10, from 116.6 ± 5.05 ms to 125.4 ± 3.80 ms, P = 0.011), which was prevented by KN-93, a CaMKII inhibitor. Increase in Ca2+ transients and shortening of Ca2+ transient duration by isoproterenol were similarly observed in both animals, which was not affected by apamin. Apamin reduced the isoproterenol-induced SVAs and maximal slope of action potential duration restitution curve specifically in SHRs. In conclusion, β- adrenoreceptor stimulation creates arrhythmogenic substrates via the CaMKII-dependent activation of SK channels in cardiac hypertrophy.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  CaMKII; Cardiac hypertrophy; Rat; SK channels; β- adrenoreceptor stimulation

Mesh:

Substances:

Year:  2018        PMID: 30529196     DOI: 10.1016/j.ejphar.2018.12.011

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy.

Authors:  Xi Zheng; Fuxiang Su; Ze Kang; Jingyuan Li; Chenyang Zhang; Yujia Zhang; Liying Hao
Journal:  Cardiovasc Ther       Date:  2022-05-02       Impact factor: 3.368

Review 2.  Cardiac small-conductance calcium-activated potassium channels in health and disease.

Authors:  Xiao-Dong Zhang; Phung N Thai; Deborah K Lieu; Nipavan Chiamvimonvat
Journal:  Pflugers Arch       Date:  2021-02-23       Impact factor: 3.657

3.  PKA phosphorylation underlies functional recruitment of sarcolemmal SK2 channels in ventricular myocytes from hypertrophic hearts.

Authors:  Shanna Hamilton; Iuliia Polina; Radmila Terentyeva; Peter Bronk; Tae Yun Kim; Karim Roder; Richard T Clements; Gideon Koren; Bum-Rak Choi; Dmitry Terentyev
Journal:  J Physiol       Date:  2019-03-20       Impact factor: 5.182

Review 4.  Regulatory mechanism of calcium/calmodulin-dependent protein kinase II in the occurrence and development of ventricular arrhythmia (Review).

Authors:  Kexin Ma; Guoping Ma; Zijing Guo; Gang Liu; Wenjie Liang
Journal:  Exp Ther Med       Date:  2021-04-20       Impact factor: 2.447

5.  RIPK3-Mediated Necroptosis in Diabetic Cardiomyopathy Requires CaMKII Activation.

Authors:  Yun Chen; Xinshuai Li; Yuyun Hua; Yue Ding; Guoliang Meng; Wei Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-06-07       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.